BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27145454)

  • 1. Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
    Park J; Kim WG; Zhao L; Enomoto K; Willingham M; Cheng SY
    Oncotarget; 2016 Jun; 7(23):34832-44. PubMed ID: 27145454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.
    Park JW; Han CR; Zhao L; Willingham MC; Cheng SY
    Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.
    Park S; Willingham MC; Qi J; Cheng SY
    Endocr Relat Cancer; 2018 Oct; 25(10):865-877. PubMed ID: 29914872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model.
    Kim WG; Park JW; Willingham MC; Cheng SY
    Endocrinology; 2013 Aug; 154(8):2936-47. PubMed ID: 23748362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
    Furuya F; Lu C; Willingham MC; Cheng SY
    Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
    Chen G; Xu S; Renko K; Derwahl M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model.
    Tang FY; Pai MH; Chiang EP
    J Nutr Biochem; 2012 Oct; 23(10):1302-13. PubMed ID: 22221675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways.
    Sarmento-Cabral A; L-López F; Gahete MD; Castaño JP; Luque RM
    Mol Cancer Res; 2017 Jul; 15(7):862-874. PubMed ID: 28385910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors.
    Cirello V; Vaira V; Grassi ES; Vezzoli V; Ricca D; Colombo C; Bosari S; Vicentini L; Persani L; Ferrero S; Fugazzola L
    Oncotarget; 2017 Feb; 8(6):9752-9766. PubMed ID: 28039458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon epithelial proliferation and carcinogenesis in diet-induced obesity.
    Takahashi H; Hosono K; Endo H; Nakajima A
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():41-7. PubMed ID: 24251703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral kanglaite injection (KLTI) attenuates the lung cancer-promoting effect of high-fat diet (HFD)-induced obesity.
    Cao N; Ma X; Guo Z; Zheng Y; Geng S; Meng M; Du Z; Lin H; Duan Y; Du G
    Oncotarget; 2016 Sep; 7(38):61093-61106. PubMed ID: 27528218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer.
    Guigon CJ; Fozzatti L; Lu C; Willingham MC; Cheng SY
    Carcinogenesis; 2010 Jul; 31(7):1284-91. PubMed ID: 20299527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term High-Fat Diet Feeding Provides Hypothalamic but Not Hippocampal Protection against Acute Infection in Male Mice.
    Astiz M; Pernía O; Barrios V; Garcia-Segura LM; Diz-Chaves Y
    Neuroendocrinology; 2017; 104(1):40-50. PubMed ID: 26862917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Am J Cancer Res; 2017; 7(3):727-739. PubMed ID: 28401024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice.
    Kim D; Lee JE; Jung YJ; Lee AS; Lee S; Park SK; Kim SH; Park BH; Kim W; Kang KP
    Int J Mol Med; 2013 Dec; 32(6):1293-302. PubMed ID: 24068196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway.
    Han B; Cui H; Kang L; Zhang X; Jin Z; Lu L; Fan Z
    Tumour Biol; 2015 Aug; 36(8):6295-304. PubMed ID: 25854169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-fat diet induced leptin and Wnt expression: RNA-sequencing and pathway analysis of mouse colonic tissue and tumors.
    Penrose HM; Heller S; Cable C; Nakhoul H; Baddoo M; Flemington E; Crawford SE; Savkovic SD
    Carcinogenesis; 2017 Mar; 38(3):302-311. PubMed ID: 28426873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high-fat diet-induced obesity on the Akt/FoxO/Smad signaling pathway and the follicular development of the mouse ovary.
    Wu Y; Zhang Z; Liao X; Qi L; Liu Y; Wang Z
    Mol Med Rep; 2016 Oct; 14(4):3894-900. PubMed ID: 27574010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression.
    Fozzatti L; Alamino VA; Park S; Giusiano L; Volpini X; Zhao L; Stempin CC; Donadio AC; Cheng SY; Pellizas CG
    Sci Rep; 2019 May; 9(1):8028. PubMed ID: 31142771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma.
    Zhu XG; Zhao L; Willingham MC; Cheng SY
    Oncogene; 2010 Apr; 29(13):1909-19. PubMed ID: 20062085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.